fluoxetine has been researched along with oxidopamine in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (16.67) | 18.7374 |
| 1990's | 12 (40.00) | 18.2507 |
| 2000's | 6 (20.00) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Grignaschi, G; Samanin, R | 1 |
| Nakamura, S | 1 |
| Tejani-Butt, SM | 1 |
| Gale, K; Meloni, R | 1 |
| Duckles, SP; Levitt, B | 1 |
| Jenner, P; Kelly, E; Marsden, CD | 1 |
| Adams, LM; Geyer, MA; Gordon, J | 1 |
| Costa, M; Cuello, AC; Elde, RP; Furness, JB; Steinbusch, HW; Verhofstad, AA | 1 |
| Kawasaki, H; Takasaki, K | 1 |
| Goodwin, WB; Guyenet, PG; Huangfu, D | 1 |
| Fuller, RW; Hemrick-Luecke, SK; Snoddy, HD | 1 |
| Baker, G; McGregor, A; Roberts, DC | 1 |
| Fawcett, JP; Menkes, DB; Patel, PP | 1 |
| Goldberg, SR; Schindler, CW; Tella, SR | 1 |
| Friedemann, MN; Gerhardt, GA; Hoffer, BJ; Luthman, J | 1 |
| Benvenga, MJ; Dreshfield, L; Fuller, RW; Gehlert, DR; Gleason, S; Hemrick-Luecke, SK; Tinsley, F; Wong, DT | 1 |
| Barrier, L; Chalon, S; Huguet, F; Page, G; Piriou, A | 1 |
| Bouvard, M; Rénéric, JP; Stinus, L | 1 |
| Cheetham, S; Jenner, P; Lane, EL | 1 |
| Barrera, G; Drolet, G; Hernandez, A; Laforest, S; Morilak, DA; Poulin, JF | 1 |
| Bechtholt, AJ; Crowley, JJ; Lucki, I; O'Leary, OF; Valentino, RJ | 1 |
| Babankova, D; Habecker, BA; Kreulen, DL; Novotny, M; Parker, LM; Spitsbergen, JM; Swain, GM; Wehrwein, EA; Wright, AA | 1 |
| Hashimoto, K; Iwata, K; Iwata, Y; Kameno, Y; Matsuzaki, H; Mori, N; Okada, K; Shinmura, C; Suda, S; Suzuki, K; Takahashi, T; Wakuda, T | 1 |
| Abe, M; Inden, M; Kitamura, Y; Minamino, H; Takata, K; Tooyama, I; Yoshimoto, K | 1 |
| Huang, BR; Lai, CH; Lin, C; Lin, H; Lin, HY; Lu, DY; Yeh, WL | 1 |
| Farajnia, S; Haddadi, R; Nayebi, AM; Sharifi, H | 1 |
| Berghauzen-Maciejewska, K; Dziubina, A; Głowacka, U; Kolasiewicz, W; Kuter, K; Ossowska, K; Wardas, J | 1 |
| Feng, H; Liu, W; Zhang, R; Zhu, H | 1 |
30 other study(ies) available for fluoxetine and oxidopamine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Role of serotonin and catecholamines in brain in the feeding suppressant effect of fluoxetine.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain; Catecholamines; Eating; Fluoxetine; Injections, Intraventricular; Male; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin | 1992 |
Effects of mianserin and fluoxetine on axonal regeneration of brain catecholamine neurons.
Topics: Adrenergic alpha-Antagonists; Animals; Axons; Cerebral Cortex; Denervation; Fluoxetine; Mianserin; Nerve Regeneration; Neurotransmitter Uptake Inhibitors; Norepinephrine; Oxidopamine; Rats; Serotonin | 1991 |
[3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
Topics: 5,7-Dihydroxytryptamine; Animals; Autoradiography; Binding, Competitive; Brain; Cerebral Cortex; Fluoxetine; Kinetics; Male; Maprotiline; Norepinephrine; Oxidopamine; Radioligand Assay; Rats; Rats, Inbred Strains; Stereoisomerism; Tritium | 1992 |
Cocaine-induced turning behavior in rats with 6-hydroxydopamine lesions: effect of transplants of fetal substantia nigra.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain Diseases; Brain Tissue Transplantation; Cocaine; Dopamine; Fetal Tissue Transplantation; Fluoxetine; Imipramine; Male; Neural Pathways; Neurotransmitter Uptake Inhibitors; Nomifensine; Oxidopamine; Piperazines; Rats; Rats, Inbred Strains; Substantia Nigra | 1991 |
Evidence against serotonin as a vasoconstrictor neurotransmitter in the rabbit basilar artery.
Topics: Animals; Basilar Artery; Female; Fluoxetine; Hydroxydopamines; In Vitro Techniques; Male; Norepinephrine; Oxidopamine; Rabbits; Serotonin; Tritium; Vasoconstriction | 1986 |
Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
Topics: Amphetamine; Animals; Catecholamines; Corpus Striatum; Desipramine; Dopamine; Female; Fluoxetine; Hydroxydopamines; Medial Forebrain Bundle; Nerve Endings; Nomifensine; Oxidopamine; Potassium Chloride; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra; Synaptosomes | 1985 |
Depletions of central norepinephrine by intraventricular xylamine in rats.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Fluoxetine; Hippocampus; Hydroxydopamines; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Nitrogen Mustard Compounds; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin | 1984 |
Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: their visualization and reactions to drug treatment.
Topics: 5,7-Dihydroxytryptamine; Animals; Desipramine; Digestive System; Fenclonine; Fluorescent Antibody Technique; Fluoxetine; Guinea Pigs; Hydroxydopamines; Mice; Myenteric Plexus; Oxidopamine; Rabbits; Rats; Reserpine; Serotonin; Submucous Plexus | 1982 |
Vasoconstrictor response induced by 5-hydroxytryptamine released from vascular adrenergic nerves by periarterial nerve stimulation.
Topics: Animals; Blood Pressure; Cocaine; Electric Stimulation; Fluoxetine; Hydroxydopamines; Male; Muscle, Smooth, Vascular; Norepinephrine; Oxidopamine; Phentolamine; Rats; Rats, Inbred Strains; Serotonin; Sympathetic Nervous System; Vasoconstriction | 1984 |
Sympatholytic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats.
Topics: Adrenergic alpha-Antagonists; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Baclofen; Blood Pressure; Brain Mapping; Desipramine; Dioxanes; Fluoxetine; gamma-Aminobutyric Acid; Idazoxan; Imidazoles; Male; Medulla Oblongata; Microinjections; Nordefrin; Oxidopamine; Rats; Rats, Sprague-Dawley; Splanchnic Nerves; Sympatholytics; Time Factors | 1995 |
Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Appetite Depressants; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Homovanillic Acid; Injections, Intraventricular; Male; Mazindol; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley | 1994 |
Effect of 6-hydroxydopamine lesions of the amygdala on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Amygdala; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Brain; Chlordiazepoxide; Cocaine; Desipramine; Dopamine; Estrus; Female; Fluoxetine; Ibotenic Acid; Injections, Intravenous; Male; Organ Specificity; Oxidopamine; Rats; Rats, Wistar; Self Administration; Time Factors; Tryptophan | 1994 |
Antidepressant treatment and chemical sympathectomy fail to modulate alpha 1-adrenoceptor sensitivity in mouse eye.
Topics: Administration, Topical; Amitriptyline; Animals; Antidepressive Agents; Benzamides; Desipramine; Down-Regulation; Fluoxetine; Injections, Intraperitoneal; Male; Methoxamine; Mice; Moclobemide; Oxidopamine; Phentolamine; Phenylephrine; Prazosin; Pupil; Receptors, Adrenergic, alpha-1; Sympathectomy, Chemical; Time Factors | 1993 |
Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system.
Topics: Adrenal Medulla; Animals; Biological Transport; Blood Pressure; Catecholamines; Chlorisondamine; Cocaine; Desipramine; Fluoxetine; Heart Rate; Male; Norepinephrine; Oxidopamine; Peripheral Nervous System; Propanolamines; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Time Factors | 1993 |
In vivo electrochemical measurements of serotonin clearance in rat striatum: effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors.
Topics: Animals; Animals, Newborn; Biogenic Monoamines; Corpus Striatum; Electrochemistry; Fluoxetine; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptosomes; Zimeldine | 1997 |
The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Carrier Proteins; Eating; Fluoxetine; Male; Mice; Mice, Inbred ICR; Motor Activity; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Oxidopamine; Paroxetine; Propylamines; Rats; Rats, Sprague-Dawley; Symporters | 1998 |
Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; In Vitro Techniques; Male; Motor Activity; Norepinephrine; Nortropanes; Oxidopamine; Piperazines; Rats; Rats, Wistar; Reserpine; Selective Serotonin Reuptake Inhibitors; Tetrabenazine | 1998 |
In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Biogenic Monoamines; Brain; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Immobilization; Male; Mianserin; Mirtazapine; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Swimming | 2002 |
Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors.
Topics: Animals; Chlorobenzenes; Cyclobutanes; Dopamine Uptake Inhibitors; Fluoxetine; Male; Motor Activity; Norepinephrine; Oxidopamine; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Rotation | 2005 |
Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals.
Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Amygdala; Animals; Anti-Anxiety Agents; Autoradiography; Behavior, Animal; Cell Count; Cholera Toxin; Drug Interactions; Fluoxetine; Galanin; Gene Expression Regulation; Immunohistochemistry; In Situ Hybridization; Locus Coeruleus; Male; Maze Learning; Norepinephrine; Oncogene Proteins v-fos; Oxidopamine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Restraint, Physical; Septal Nuclei; Stilbamidines; Stress, Physiological; Tritium; Yohimbine | 2006 |
The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Benzylamines; Cerebral Cortex; Citalopram; Desipramine; Dopamine beta-Hydroxylase; Fluoxetine; Hindlimb Suspension; Immunohistochemistry; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Norepinephrine; Oxidopamine; Presynaptic Terminals; Raphe Nuclei; Selective Serotonin Reuptake Inhibitors | 2007 |
Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content.
Topics: Animals; Blotting, Western; Fluoxetine; Heart; Immunohistochemistry; Male; Myocardium; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Oxidopamine; Rats; Rats, Sprague-Dawley; Stellate Ganglion; Sympathectomy, Chemical; Sympatholytics; Tritium | 2008 |
Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.
Topics: Adrenergic Agents; Animals; Cell Differentiation; Cell Proliferation; Cell Survival; Dopamine; Fluoxetine; Glial Fibrillary Acidic Protein; Hippocampus; Humans; Immunohistochemistry; Maze Learning; Mesencephalon; Motor Activity; Neurons; Oxidopamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tyrosine 3-Monooxygenase | 2010 |
Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dopaminergic Neurons; Fluoxetine; Histones; Levodopa; Male; MAP Kinase Signaling System; Oxidopamine; Parkinson Disease; Phosphorylation; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Substantia Nigra; Tyrosine 3-Monooxygenase | 2012 |
Desipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neurons.
Topics: Animals; Antidepressive Agents; Cell Death; Cell Nucleus; Cell Survival; Desipramine; Dopaminergic Neurons; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fluoxetine; Heme Oxygenase-1; MAP Kinase Kinase 4; Mice; Neurodegenerative Diseases; Neurons; NF-E2-Related Factor 2; Oxidopamine; Rats; Rhodamines; RNA, Small Interfering; Signal Transduction; Transfection; Trypan Blue | 2012 |
Effect of Chronic Administration of Buspirone and Fluoxetine on Inflammatory Cytokines in 6-Hydroxydopamine-lesioned Rats.
Topics: Animals; Buspirone; Cerebrospinal Fluid; Fluoxetine; Interleukin-1beta; Interleukin-6; Male; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Tumor Necrosis Factor-alpha | 2015 |
Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease.
Topics: Animals; Antidepressive Agents; Benzothiazoles; Depression; Disease Models, Animal; Dopamine Agonists; Fluoxetine; Imipramine; Male; Motor Activity; Oxidopamine; Parkinson Disease; Pramipexole; Rats; Rats, Wistar; Swimming; Treatment Outcome | 2014 |
Fluoxetine tunes the abnormal hippocampal oscillations in association with cognitive impairments in 6-OHDA lesioned rats.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Brain Waves; Cognitive Dysfunction; Disease Models, Animal; Fluoxetine; Hippocampus; Male; Maze Learning; Oxidopamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2021 |